N94-15226-15423 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-12-23
Dose 1 — Pfizer-BioNTech
2022-01-14
Dose 2 — Pfizer-BioNTech
2022-06-23
Registered in v-safe
2022-07-15
Survey response — 6 months, dose 2, dependent
MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Viral cold

MedDRA releases: 2024-11 · check-in free text available
2022-07-15
Report sent to call center — 6 months, dose 2, dependent
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-07-18
Call successful
Not applicable - Accidental Reporting
2023-01-14
Health check-in — 12 months, dose 2, dependent
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-12-23	Pfizer-BioNTech	No
2	2022-01-14	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-07-15	Successful 2022-07-18	Not applicable - Accidental Reporting

Free text

Release 12 — 6 months, dose 2, dependent

2022-07-15

Symptoms: Viral cold

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Nasopharyngitis	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release